Home › Depression › California › Sacramento
Depression clinical trials in Sacramento, CA
4 studies for Depression are looking for participants at sites in and around Sacramento (within about 30 miles). Open a study to see who can join and how to contact the study team.
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- Kaiser Permanente Downtown Commons, Sacramento
- Kaiser Permanente-South Sacramento, Sacramento
Supporting Mental Health and Reducing Care Stress in Caregivers of Persons With Cardiovascular Disease
Recruiting
- University of California Davis Health System, Sacramento
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RecruitingPhase 3
- University of California Davis Health /ID# 268306, Sacramento
Cognition and Behavior With Sham Accelerated TMS
Recruiting
- UC Davis Medical Center, Sacramento
About Depression
Depression is a serious medical illness. It affects almost 7 percent of U.S. adults. It causes feelings of sadness, hopelessness, and frustration that do not go away. Learn about treatments.
More about Depression on MedlinePlus
Depression trials in other cities
- Boston, MA51 studies
- New York City, NY46 studies
- Philadelphia, PA24 studies
- Chicago, IL23 studies
- Pittsburgh, PA22 studies
- Atlanta, GA22 studies
- San Diego, CA21 studies
- Charleston, SC19 studies
- Houston, TX18 studies
- Los Angeles, CA17 studies
- Orlando, FL17 studies
- Miami, FL16 studies
Other studies in Sacramento
- Non-Small Cell Lung Cancer29 studies
- Lung Cancer22 studies
- Breast Cancer20 studies
- Prostate Cancer19 studies
- Metastatic Cancer16 studies
- Heart Failure12 studies
- Cancer (all types)12 studies
- Acute Myeloid Leukemia12 studies
- Pancreatic Cancer12 studies
- Bladder Cancer10 studies
- Colorectal Cancer10 studies
- Colon Cancer10 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.